Deborah Toppmeyer, MD, is an expert in breast cancer, breast cancer genetics, and the design and implementation of clinical trials that offer promising new therapies targeted to specific types of breast cancer. She helps her patients navigate through treatment options while encouraging enrollment in clinical trials, and simultaneously provides opportunities for students to learn cancer biology, cancer pharmacology, genetics, and clinical care.

Toppmeyer is the author or co-author of more than 50 publications and serves on the editorial board of the journal Clinical Cancer Research. She is a core member for the Breast Committee of the Eastern Cooperative Oncology Group, one of the nation’s largest clinical cancer research organizations.

Toppmeyer also is involved with the Rutgers-Botswana Partnership for Health’s cancer control and prevention initiatives in Botswana. Rutgers Global Health Institute and Rutgers Cancer Institute have developed a 12-month global oncology elective and research program in the hematology/oncology fellowship program. This elective is intended to introduce fellows to the complexities of cancer care and prevention in an African setting and offer exposure and training for possible careers in global oncology.

Learn more about Toppmeyer and her work.